5 Boring Stocks With Exciting Dividends
I am somewhat amazed at what’s been going on in the market for the last week or so.
Top 10 Shipping Companies To Invest In Right Now: Centor Energy Inc (CNTO)
Centor Energy Inc, formerly Centor, Inc., incorporated on February 16, 2011, is an exploration-stage company. The Company is engaged in the business of mineral exploration.
On November 26, 2012, the Company entered into a purchase agreement with Bullnet Gold Resources Limited. As of May 31, 2013, the Company had not generated revenues. As of May 31, 2013, the Company had no mining operations.
Advisors' Opinion:- [By John Udovich]
While Bakken formation oil and gas stocks have grabbed the attention of�American investors, small cap Alberta or Saskatchewan oil and gas stocks Advantage Oil & Gas Ltd (NYSE: AAV), Sonde Resources Corp (NYSEMKT: SOQ) and up and coming Centor Energy Inc (OTCBB: CNTO) have been largely overlooked as they seek to exploit oil and gas (including oil sands) in the resource rich Canadian provinces of Alberta or Saskatchewan or seek strategic alternatives for their assets in these areas or themselves. It should be mentioned that Canada�� oil reserves are third only to Venezuela and Saudi Arabia with over 95% of these reserves being the oil sands of Alberta plus that province contains much of the country�� conventional oil reserves as well. In addition, the province of Saskatchewan along with offshore areas of Newfoundland contain substantial production and reserves. Excluding oil sands, Alberta would have 39% of Canada�� remaining conventional oil reserves,�followed by�offshore Newfoundland with�28% and Saskatchewan with 27%.
- [By James E. Brumley]
Quick, what do Chesapeake Energy Corporation (NYSE:CHK), Centor Energy Inc. (OTCBB:CNTO), and Total SA (NYSE:TOT) have in common? If you said "they're all energy companies" then technically you're right. It's not necessarily the meaningful answer that we were looking for, however. No, the more significant commonalty between TOT, CHK, and CNTO right now could be that (1) 20 years ago, nobody thought they'd be having any real success doing something they're all three now involved in.... shale mining. Yet, reality is reality. While Chesapeake Energy is best known as a natural gas play, its heavy fiscal lifting is actually being done by its oil shale mining efforts in Eagle Ford, Texas. Total SA is more of a tradition integrated oil and gas company, but it too has found success - and profits - in the shale business. What's that got to do with Centor Energy? Centor is simply following a well-proven oil shale lead. It's just doing so in a newly-proven region of the world that's rich in the resource.
- [By John Udovich]
Many American oil and gas investors are probably familiar with the major large and small cap players in the Bakken formation in North Dakota and Montana, but few American investors are probably familiar with�the active players further to the north in the�oil and gas rich Canadian provinces of Saskatchewan and Alberta�with small cap stocks like Alexander Energy Ltd (CVE: ALX), Renegade Petroleum Ltd (CVE: RPL) and Centor Energy Inc (OTCBB: CNTO) along with large cap Suncor Energy Inc (NYSE: SU) being among those�pumping out their share of noteworthy news lately. I should point out that�Canada�� oil reserves are ranked #3 after to Venezuela and Saudi Arabia with over 95% of these reserves being the controversial�oil sands of Alberta while the neighboring province of Saskatchewan (which the Bakken formation actually stretches into) along with offshore areas of Newfoundland also containing substantial production and reserves. Moreover and excluding the oil sands, Alberta would have 39% of Canada�� remaining conventional oil reserves,�followed by�offshore Newfoundland with�28% and Saskatchewan with 27%.
Top 10 Shipping Companies To Invest In Right Now: Pharmacyclics Inc (PCYC)
Pharmacyclics, Inc., incorporated on April 19, 1991, is a clinical-stage biopharmaceutical company focused on developing and commercializing small-molecule drugs for the treatment of cancer and immune mediated diseases. The Company's clinical development and product candidates are small-molecule enzyme inhibitors designed to target biochemical pathways involved in human diseases. As of June 30, 2011, it had three drug candidates under clinical development and a number of preclinical lead molecules. This includes an inhibitor of Bruton�� tyrosine kinase (Btk) (PCI-32765) in Phase II studies in hematologic malignancies; a Btk inhibitor lead optimization program targeting autoimmune indications, an inhibitor of Factor VIIa (PCI-27483) in a Phase II clinical trial in pancreatic cancer, and a histone deacetylase (HDAC) inhibitor (PCI-24781) in Phase I and II clinical trials in solid tumors and hematological malignancies as of June 30, 2012.
As of June 30, 2012, the Company developed ibrutinib, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a variety of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin�� lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse B-cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indications of its current or planned Phase Ib/II and Phase III development program. had development programs for B-cell malignancies and autoimmune diseases. For malignant indications it has developed PCI-32765, which has demonstrated clinical activity and tolerability in Phase I and Phase II clinical trials in a range of B-cell malignancies, including chronic lymphocytic leukemia (CLL) and a number of non-Hodgkin�� lymphoma (NHL) subtypes. CLL, mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse large B cell lymphoma (DLBCL) and multiple myeloma (MM) are specific indications of its Phase II development. It has developed an assay! to measure occupancy of Btk in PBMCs using a cell-permeable fluorescently-labeled derivative of PCI-32765.
Factor VII is an enzyme that becomes activated (FVIIa) by binding to the cell surface protein tissue factor (TF), a protein found in the body that helps to trigger the process of blood clotting in response to injury. TF is over expressed in many cancers including gastric, breast, colon, lung, prostate, ovarian and pancreatic cancers. In these tumors, the FVIIa/TF complex induces intracellular signaling pathways by activating protease activated receptor 2 (PAR-2), another cell-surface protein. This in turn increases the expression of interleukin-8 (IL-8), a protein produced by white blood cells and other immune cells in response to pathogenic stimulation, and vascular endothelial growth factor (VEGF), a signal protein produced by cells that stimulate the growth of blood vessels. Both proteins play an important role in tumor growth and metastases as well as angiogenesis (growth of new blood vessels). FVIIa/TF complex also initiates the coagulation (a process by which blood forms clots) processes implicated in the high incidence of thromboembolic (the process by which the blood clots within a blood vessel) complications seen in patients with TF-expressing cancers. Thromboembolic events are a cause of death in patients with cancer and anticoagulant treatment has been shown to improve survival in a variety of cancers (Klerk et al. JCO. 2005).
PCI-27483 Factor VIIa Inhibitor
The Company�� Factor VIIa inhibitor PCI-27483 is a first-in-human small molecule inhibitor that selectively targets FVIIa. As an inhibitor of FVIIa, PCI-27483 has two potential mechanisms of action: inhibition of intracellular signaling involved in tumor growth and metastases and inhibition of early coagulation processes associated with thromboembolism.
Factor VIIa PCI-27483 Clinical Development Update
A multicenter Phase I/II of PCI-27483 in patients with locally a! dvanced o! r metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phase II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). The objectives are to assess the safety of FVIIa Inhibitor PCI-27483 at pharmacologically active dose levels, to assess potential inhibition of tumor progression and to obtain initial information of the effects on the incidence of thromboembolic events. Due to a paradigm shift away from the use of gemcitabine alone for the treatment of pancreatic cancer, enrolling patients in this randomized study has been challenging. PCYC is evaluating other alternatives for development of this agent.
A multicenter Phase I/II of PCI-27483 in patients with locally advanced or metastatic pancreatic cancer that are either receiving or are planned to receive gemcitabine therapy has completed enrollment. The Phase II portion of the study randomized patients to receive either gemcitabine alone or gemcitabine plus PCI-27483 (1.2 mg/kg twice daily). PCI-27483 is covered by United States patents and patent applications and counterpart patents and patent applications in fourteen ex-United States territories, including Europe, Canada, Mexico, Japan, China, India, South Korea, Australia and Brazil.
Advisors' Opinion:- [By John McCamant]
The company��hich we consider conservative among biotech stocks��s Pharmacyclics (PCYC). Its pill is also expected to be approved for a much larger B-cell cancer market, chronic lymphocytic leukemia (CLL), by the end of February.
- [By Maxx Chatsko]
The astounding rise of Pharmacyclics (NASDAQ: PCYC ) through the markets has been largely based on its BTK inhibitor ibrutinib, which is being evaluated in four types of blood cancers and in a preclinical study for autoimmune indications. The rise is no fluke, either. Ibrutinib has shown very promising results in two phase 2 trials as a monotherapy and will soon be moved to phase 3 trials for both. With billions of dollars between the lymphoma and autoimmune markets up for grabs, it is easy to see why shares have risen 2,000% since the company acquired its lead drug candidate in 2006. Can Celgene tap into this multibillion opportunity with CC-292? Ask me again in about five years.�
- [By Keith Speights]
Last year, Pharmacyclics (NASDAQ: PCYC ) shares gained a whopping 280%. That was enough to land the biotech a spot on The Motley Fool's list of top health-care stocks in 2012. How is 2013 looking so far? Shares have gained more than 30% year to date but have been anemic since early March.
Top 10 Insurance Companies To Invest In Right Now: Saratoga Investment Corp(SAR)
Saratoga Investment Corp. is a business development company specializing in buyout, acquisition, growth, recapitalization, and note financing transactions of private middle market companies. It structures its investments as debt and equity by investing through first and second lien loans, mezzanine debt, select high yield bonds, senior secured bonds, unsecured bonds, and preferred and common equity. It seeks to invest in the United States. The firm primarily invests in companies having EBITDA between $5 million and $50 million. It invests through direct lending as well as participation in loan syndicates. The firm was formerly known as GSC Investment Corp. Saratoga Investment Corp. is based in New York, New York with an additional office in Florham Park, New Jersey.
Advisors' Opinion:- [By Laura Brodbeck]
Monday
Earnings Releases Expected: Citigroup Inc. (NYSE: C), Saratoga Investment Corp. (NYSE: SAR), Bank of the Ozarks (NASDAQ: OZRK) Economic Releases Expected: Japanese industrial production, eurozone industrial productionTuesday
Top 10 Shipping Companies To Invest In Right Now: Frozen Food Express Industries Inc.(FFEX)
Frozen Food Express Industries, Inc., together with its subsidiaries, provides temperature-controlled truckload and less-than-truckload services in the United States. It offers truckload linehaul, dedicated fleets, and less-than-truckload linehaul services, as well as brokerage services, including ocean, air, and domestic and international expedited services. The company primarily transports meat, ice, poultry, seafood, processed foods, candy and other confectionaries, dairy products, pharmaceuticals, medical supplies, fresh and frozen fruits and vegetables, cosmetics, films, and Christmas trees. It also leases refrigerated trailers for the storage and transportation of perishable items. As of September 30, 2011, the company operated a fleet of 1,178 tractors and 2,360 trailers. Frozen Food Express Industries, Inc. was founded in 1946 and is based in Dallas, Texas.
Advisors' Opinion:- [By John Udovich]
Despite what can best be described as a�soft economy, small cap trucking stocks YRC Worldwide, Inc (NASDAQ: YRCW), Arkansas Best Corporation (NASDAQ: ABFS), Frozen Food Express Industries, Inc (NASDAQ: FFEX), Saia Inc (NASDAQ: SAIA) and USA Truck, Inc (NASDAQ: USAK) have been trucking some pretty impressive returns since the start of the year. In fact, these small cap trucking stocks are up anywhere from 72% to 150% or so since the start of the year despite the slow economy. Certainly trucking stocks provide a good indicator of how the economy is doing, but might investors be�jumping the gun by pushing up these trucking stocks?
Top 10 Shipping Companies To Invest In Right Now: The Greenbrier Companies Inc (GBX)
The Greenbrier Companies, Inc. (Greenbrier), formerly Greenbrier Oregon, Inc., incorporated on October 24, 2005, are the designers, manufacturers and marketers of railroad freight car equipment in North America and Europe, a manufacturer and marketer of ocean-going marine barges in North America and a provider of wheel services, railcar refurbishment and parts, leasing and other services to the railroad and related transportation industries in North America. The Company operates in three business segments: Manufacturing; Wheel Services, Refurbishment & Parts; and Leasing & Services.
The Manufacturing segment, operating from facilities in the United States, Mexico and Poland, produces double-stack intermodal railcars, conventional railcars, tank cars and marine vessels.
The Wheel Services, Refurbishment & Parts segment performs wheel, axle and bearing servicing; railcar repair, refurbishment and maintenance activities; as well as production and reconditioning of a variety of parts for the railroad industry in North America. The Leasing & Services segment owns approximately 11,000 railcars and provides management services for approximately 219,000 railcars for railroads, shippers, carriers, institutional investors and other leasing and transportation companies in North America. The Company produces rail castings through an unconsolidated joint venture.
Manufacturing
The Manufacturing segment manufactures a broad array of railcar types in North America which includes railcar types other than coal cars. The primary products offered by the Company include Intermodal Railcars, Conventional Railcars, Tank Cars, European Railcar Manufacturing and Marine Vessel Fabrication. The Company manufactures a range of intermodal railcars. The important intermodal product is articulated double-stack railcar. The double-stack railcar is designed to transport containers stacked two-high on a single platform. The Company produces a range of boxcars, which are used in t! he transport of forest products, automotive, perishables, general merchandise and commodities. It also produces covered hopper cars for the grain, energy, sand and cement industries as well as gondolas for the steel and metals markets and various other conventional railcar types, including Auto-Max car.
The Company�� European manufacturing operation produces a variety of railcar (wagon) types, including a line of pressurized tank cars for liquid petroleum gas and ammonia and non-pressurized tank cars for light oil, chemicals and other products. It also produces flat cars, coil cars for the steel and metals market, coal cars for both the continental European and United Kingdom markets, gondolas, sliding wall cars and automobile transporter cars.
The Company�� Portland, manufacturing facility, located on a deep-water port on the Willamette River, includes marine vessel fabrication capabilities. It manufactures range of Jones Act ocean-going and river barges for transporting merchandise between ports within the U.S. including conventional deck barges, double-hull tank barges, railcar/deck barges, barges for aggregates and other heavy industrial products and dump barges. It focuses on the ocean-going vessels and coal carrying river barges although the facility has the capability to compete in other marine related products.
Wheel Services, Refurbishment and Parts.
Wheel Services, Railcar Repair, Refurbishment and Component Parts Manufacturing segment operates in the independent wheel services, repair, refurbishment and component parts networks in North America, operating in 39 locations. The wheel shops, operating in 12 locations, provide complete wheel services including reconditioning of wheels, axles and roller bearings in addition to new axle machining and finishing and axle downsizing. Its network of railcar repair and refurbishment shops, operating in 23 locations, performs heavy railcar repair and refurbishment, as well as routi! ne railca! r maintenance. It is engaged in the repair and refurbishment of railcars for third parties, as well as of its own leased and managed fleet. Its component parts facilities, operating in four locations, recondition railcar cushioning units, couplers, yokes, side frames, bolsters and various other parts. It also produces roofs, doors and associated parts for boxcars.
Leasing and Services
Leasing-The Company offers flexible financing programs including operating leases and by the mile leases to the customers . The Company leases are full service leases whereby the Company is responsible for maintenance and administration. Maintenance of the fleet is provided, in part, through its own facilities and engineering and technical staff.
Management Services- management services business offers a broad array of software and services that include railcar maintenance management, railcar accounting services, such as billing and revenue collection, car hire receivable and payable administration, total fleet management including railcar tracking using software, administration and railcar remarketing. The Company provide management services for a fleet of approximately 230,000 railcars for railroads, shippers, carriers, institutional investors and other leasing and transportation companies in North America.
Advisors' Opinion:- [By Monica Gerson]
The Greenbrier Companies (NYSE: GBX) is projected to report its Q3 earnings at $0.74 per share on revenue of $571.07 million.
UniFirst (NYSE: UNF) is estimated to report its Q3 earnings at $1.42 per share on revenue of $349.24 million.
Top 10 Shipping Companies To Invest In Right Now: PGT Inc.(PGTI)
PGT, Inc. engages in the manufacture and supply of residential impact-resistant windows and doors. The company offers impact-resistant products, including heavy-duty aluminum or vinyl frames with laminated glass to provide protection from hurricane-force winds and wind-borne debris. It also provides a range of non-impact-resistant aluminum and vinyl frame windows and doors; Architectural Systems line of products, which offer protection from hurricane-force winds and wind-borne debris for mid-and high-rise buildings; and non-glass vertical and horizontal sliding panels for porch enclosures, such as vinyl-glazed and aluminum-framed products used for enclosing screened-in porches that provide protection from inclement weather. The company markets its products under the WinGuard, PremierVue, PGT Architectural Systems, Eze-Breeze, and SpectraGuard brand names. PGT, Inc. offers its products to residential new construction, and home repair and remodeling end markets through windo w distributors, building supply distributors, window replacement dealers, and enclosure contractors. It operates in the southeastern United States, the Gulf Coast, Coastal mid-Atlantic, the Caribbean, Central America, and Canada. The company was formerly known as JLL Window Holdings, Inc. and changed its name to PGT, Inc. in January 2004. PGT, Inc. was founded in 1980 and is based in North Venice, Florida.
Advisors' Opinion:- [By Eric Volkman]
A larger-than-previously announced block of PGT's (NASDAQ: PGTI ) shares is up for grabs. Major stockholder JLL Partners Fund has increased the size of its sale; it is now offering an even 10 million shares in an underwritten secondary public offering priced at $7.75 per share. Also, the issue's underwriters have been granted a 30-day option to buy up to an additional 1.65 million shares from the seller.
- [By Seth Jayson]
There's no foolproof way to know the future for PGT (Nasdaq: PGTI ) or any other company. However, certain clues may help you see potential stumbles before they happen -- and before your stock craters as a result.
Top 10 Shipping Companies To Invest In Right Now: Eco-Tek Group Inc (ETEK)
Eco-Tek Group, Inc., incorporated on April 10, 2007, is engaged in manufacturing and marketing of green lubricants and specialized systems with an automotive sector but also applicable to a variety of industrial, farm and virtually all mechanical equipment. The Company�� products include Eco-Tek Super Lubricant, Eco-Tek 3000 Synthetic Motor Oil, Eco-Tek 4-in-1 Fuel Treatments, Eco-Tek HD Synthetic Oil Stabilizer, Eco-Tek Bypass Oil Cleaner, Eco-Tek Engine Flush, Eco-Tek Lube Centres, Eco-Tek Test-Results, Eco-Tek Our Inventor and Eco-Tek Limited Warranty.
The Company�� motor oil and lubricant is zinc free. Eco-Tek Engine Flush which cleans internal engine components extends engine life and restores lost performance due to sludge and buildup. Eco-Tek Premium Orange Hand Cleaner, which contains pumice to clean, aloe and lanolin to moisturize. Eco-Tek Non-Toxic Super Lubricant, reduces friction, fuel consumption, harmful contaminants in oil, reduces smoke, vibration and noise.
Advisors' Opinion:- [By Peter Graham]
Small cap green stocks Eco-Tek Group Inc (OTCMKTS: ETEK) and BluForest Inc (OTCMKTS: BLUF) have been getting some attention lately thanks to some green���as in paid for promotions. Of course, there is nothing wrong with properly disclosed promotions, but one of these stocks happens to be getting a considerable amount of attention as its been the subject of numerous transactions. With that in mind, will investors see some green with these green small cap stocks? Here is a quick reality check:�
Top 10 Shipping Companies To Invest In Right Now: St. Jude Medical Inc.(STJ)
St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in four segments: Cardiac Rhythm Management, Cardiovascular, Atrial Fibrillation, and Neuromodulation. The Cardiac Rhythm Management segment offers products for cardiac arrhythmias, or irregular heart beats. Its products include tachycardia implantable cardioverter defibrillator systems to provide therapy to patients suffering from lethal heart conditions, such as sudden cardiac arrest; cardiac resynchronization therapy devices to treat heart failure patients; pacemakers to help people whose hearts beat too slowly or who suffer from other cardiac arrhythmias; and leads, which connect devices to the heart and carry the electrical impulses to the heart and information from the heart to the device. The Cardiovascular segment offers mechanical and tissue replacement heart valves, as well as heart valve repair products. It also pr ovides disposable interventional devices, including vascular closure devices, compression assist devices, percutaneous catheter introducers, diagnostic guidewires, and temporary bipolar pacing catheters, as well as diagnostic coronary imaging technology. The Atrial Fibrillation segment offers a system of products for access, diagnosis, visualization, and ablation that assist physicians in diagnosing and treating various irregular heart rhythms used in the electrophysiology lab and cardiac surgery. It provides electrophysiology introducers and catheters, cardiac mapping, navigation and recording systems, and ablation systems. The Neuromodulation segment offers a range of neurostimulation systems, such as rechargeable implantable pulse generators, primary cell implantable pulse generators, and radio frequency powered systems. St. Jude Medical markets its products through a direct sales force and independent distributors. The company was founded in 1976 and is headquartered in St. Paul, Minnesota.
Advisors' Opinion:- [By Dan Carroll]
Why is this important? Medtronic's battling with Edwards Lifesciences's (NYSE: EW ) Sapien heart valve for market share in Europe, and upstarts Boston Scientific (NYSE: BSX ) and St. Jude Medical (NYSE: STJ ) are looking to punch into the European industry with their Lotus and Portico valves, respectively. Medtronic's valve-in-valve approval gives the company a leg up on its competition, but is it enough to entrench this firm as a leader in the industry? Motley Fool contributor Dan Carroll and health-care analyst Max Macaluso discuss what you need to know below.
- [By Dan Carroll]
It's safe to say medical-device maker St. Jude Medical (NYSE: STJ ) has had a big year. This stock's jumped more than 50% year to date as part of health care's rise in 2013. However, as shares have risen, St. Jude's sales and earnings haven't taken the same path higher.
Top 10 Shipping Companies To Invest In Right Now: Verifone Systems Inc.(PAY)
Verifone Systems, Inc. designs, markets, and services electronic payment solutions in North America and internationally. It provides system solutions, including countertop electronic payment systems that accepts magnetic, smart card, contactless/ radio frequency identification(RFID) cards, and near field communication(NFC) enabled mobile phones; secure PIN pads that support credit and debit transactions; and wireless system solutions that support Internet protocol-based code division multiple access, general packet radio service, bluetooth, and wireless fidelity technologies. The company also offers products for consumer-activated functionality at the point of sale; contactless/NFC payment solutions consisting of contactless readers primarily for consumer-activated transactions with contactless cards, tokens, and NFC-enabled mobile phones; and Gemstone family of products comprising integrated electronic payment systems for petroleum companies. In addition, it provides serv er-based payment processing software and middleware; unattended and self-service payments hardware and software integration modules, such as vending machines, ATMs, ticketing kiosks, petroleum dispensers, public transportation turnstiles and buses, self-checkout, bill payment, and photo finishing kiosks; retail bank branch solutions; mass transportation solutions; and network access solutions. Further, the company offers client services, customized application development, advertising publishing, taxi payments and advertising, cardholder data security, annual software maintenance program, and repair services. It serves financial institutions, payment processors, petroleum companies, large retailers, taxi fleets, government organizations, healthcare companies, independent sales organizations, and advertisers. The company was formerly known as VeriFone Holdings, Inc. and changed its name to VeriFone Systems, Inc in May 2010. VeriFone Systems, Inc. is headquartered in San Jose, California.
Advisors' Opinion:- [By Monica Gerson]
VeriFone Systems (NYSE: PAY) is expected to report its Q3 earnings at $0.35 per share on revenue of $458.93 million.
Joy Global (NYSE: JOY) is estimated to report its Q3 earnings at $0.84 per share on revenue of $934.25 million.
Top 10 Shipping Companies To Invest In Right Now: Ark Restaurants Corp. (ARKR)
Ark Restaurants Corp., through its subsidiaries, engages in the ownership and operation of restaurants and bars, fast food concepts, and catering operations. As of October 2, 2010, it owned and operated 22 restaurants and bars, including 9 facilities located in New York City; 4 in Washington, D.C.; 5 in Las Vegas, Nevada; 2 in Atlantic City, New Jersey; 1 at the Foxwoods Resort Casino in Ledyard, Connecticut; and 1 in the Faneuil Hall Marketplace in Boston, Massachusetts, as well as had 29 fast food concepts and catering operations. The company was founded in 1983 and is based in New York, New York.
Advisors' Opinion:- [By Geoff Gannon] ght them - and even now - I think their return on buyback would be high and I'd be in favor of it. However, the stocks are illiquid and their free cash flow relative to the dollar value of freely traded shares is not high. As a result, I'm always in favor of RSKIA and ARKR buying back stock. But, I understand it's very hard for them to do in practice unless there is a meaningful holder who signals he wants out of the stock.
My approach to buybacks is pretty simple. One, I prefer them. Two, I look at the share count history over the last 10 to 20 years as my guide to what the company might do in the future - I want a pattern of predictable behavior. Generally, that means a continuously shrinking share count that shrinks in bull markets and bear markets, panics and recessions and booms and busts and so on. Three, if I'm a buyer of the stock - then the company should be a buyer of its own stock. No questions asked on that one. If the stock is good enough for me to buy it's clearly good enough for the company to buy. Finally, I look for the return on buyback. I tend to focus on the earning power the company is buying relative to the net cash it is spending. If a company has cash on its balance sheet, the amount of net cash consumed by a buyback will be less than it appears because I will end up with a greater percentage ownership of the resulting balance sheet as well as the income statement.
I want the return on buyback to always be at least 10%. As a rule, the average company will only get returns on its buybacks of 10% or higher if it pays less than 15 times normal earnings. In special cases - fast growing companies, companies where free cash flow vastly exceeds reported income, etc. - it is possible that buybacks above 15 times earnings will return more than 10%. It almost never makes sense for a company to buy back stock at over 25 times earnings. So, for most companies, under 15 times earnings is the green zone for buybacks - 15 to 25 times earnings is
- [By Bram de Haas]
Ark Restaurants Corp (ARKR) owns and operates 19 restaurants and bars, 22 fast food concepts and catering operations in the USA. This is a short article outlining why they are an interesting company to put on the buy list. It needs to be said, this is not a chain that can roll out their concept or brand nationwide and enjoy terrific growth of their franchise. They chose not to build up brands and instead operate under trade names that suit the unique locations they prefer. The reason that I want to highlight this small company is that in recent years they have faced numerous challenges and adversity (aside from those posed by the general economy) and it's possible they have dealt with the majority, and free cash flow will enjoy a significant uptick in the next two years.
No comments:
Post a Comment